Medicare Enrolled

Dr. Angela Scheuerle, M.D.

Clinical Genetics (M.D.) Physician · Dallas, TX
5323 HARRY HINES BLVD, Dallas, TX 75390
2144569093
Registered in NPPES since 2006
NPI: 1073570586 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Scheuerle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scheuerle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Scheuerle

Dr. Angela Scheuerle is a clinical genetics physician in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Scheuerle received a total of $139,530 from 25 pharmaceutical and/or device companies across 721 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Scheuerle is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $139,530 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$139,530
Total received (2018-2024)
Avg $19,933/year across 7 years
Top 12% in TX for clinical genetics (m.d.) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
721
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,910
2023
$11,114
2022
$12,508
2021
$20,289
2020
$16,257
2019
$14,529
2018
$34,923

Payments by company (2024)

ABBVIE INC.
$15,886
UCB SA
$9,500
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,600
Merck Sharp & Dohme LLC
$962
Hikma Pharmaceuticals USA
$936
Amneal Pharmaceuticals LLC
$896
ViiV Healthcare Company
$65
GENZYME CORPORATION
$35
Takeda Pharmaceuticals U.S.A., Inc.
$30
Top 3 companies account for 90.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB SA
$47,125
Lupin Inc.
$20,267
ABBVIE INC.
$18,170
ViiV Healthcare Company
$11,196
UCB Biosciences Inc.
$6,625
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,020
Amneal Pharmaceuticals LLC
$4,105
Genentech, Inc.
$3,783
Merck Sharp & Dohme LLC
$3,226
Hikma Pharmaceuticals USA
$2,863
Merck Sharp & Dohme Corporation
$2,650
AbbVie Inc.
$2,583
Sandoz Inc.
$2,546
Mylan Inc.
$2,181
SANOFI US SERVICES INC.
$2,178
AbbVie, Inc.
$1,715
F. Hoffmann-La Roche AG
$1,411
Gilead Sciences, Inc.
$964
GlaxoSmithKline, LLC.
$696
GENZYME CORPORATION
$76
Takeda Pharmaceuticals U.S.A., Inc.
$72
Cycle Pharmaceuticals Inc
$28
Sobi, Inc
$25
BioMarin Pharmaceutical Inc.
$13
Retrophin, Inc.
$9
Top 3 companies account for 61.3% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · AUBAGIO · Abacavir Sulfate · DUPIXENT · ELAPRASE · ENTECAVIR · Fuzeon · GENERIC · ISENTRESS · LEMTRADA · LUMIZYME · NEVIRAPINE · NORVIR · Nityr · Norvir · TIVICAY · VPRIV · Xolair · Zidovudine
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a clinical genetics physician in Dallas?
Compare clinical genetics physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse clinical genetics physicians nearby

Geographic Context

Clinical genetics physicians in nearby ZIP areas
9
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Scheuerle is a clinical genetics physician, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Scheuerle receive payments from pharmaceutical companies?
Yes. Dr. Scheuerle received a total of $139,530 from 25 companies across 721 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Scheuerle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Clinical Genetics Physicians in Dallas
Browse clinical genetics physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Clinical Genetics Physicians in TX
Clinical genetics physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Genetics Physicians in TX
Which TX clinical genetics physicians receive the most from drug and device companies.
By company
UCB SA Payments to Doctors
See all physicians who received payments from UCB SA.
By company
Lupin Inc. Payments to Doctors
See all physicians who received payments from Lupin Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →